Procognia procognia.com


Public lists: Pharma Startups (4732)

Procognia is focused on exploiting the ever-expanding knowledge of proteins to increase the quality of biopharmaceuticals and small molecule therapeutics. The company has developed two technology platforms that aims to set new standards of scale, sensitivity, specificity and accuracy in glycoanalysis and proteomics analysis within the pharmaceutical industry.

Procognia is focused on exploiting the ever-expanding knowledge of proteins to increase the quality of biopharmaceuticals and small molecule therapeutics. The company has developed two technology platforms that aims to set new standards of scale, sen...Show all

Company (IPO / Went public)

Phone: +972 886 34300

Fax:

3 Habosem Street

77610
Israel

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Procognia $12M Dec 10, 2006
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Procognia Jobs

jobs by Indeed job
						search

Competitors

Company Status Description Investors

Catalyst Biosciences

South San Francisco, California, United States
MergedCatalyst Biosciences is developing next generation biopharmaceuticals by harnessing the catalytic power of engineered proteases that target proteins underlying diseases. Catalyst's discovery platform rapidly creates and optimizes tailor-made protease drug candidates that cleave a wide variety of disease targets, either by improving existing protease drugs or by creating new protease drugs, known as Alterase therapeutics. Catalyst is focusing its product development efforts on drug candidates for...Show allLogin to see details

OraPharma

Horsham, Pennsylvania, United States
AcquiredOraPharma is a specialty pharmaceutical company that develops and commercializes products that improve and maintain oral health. The company is dedicated to delivering scientifically and technologically advanced products to dental professionals and their practices. OraPharma's lead product, ARESTIN (minocycline hydrochloride), is a locally administered antibiotic for the treatment of periodontitis that utilizes an advanced controlled-release delivery system. In February 2003, OraPharma was acqu...Show allLogin to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Method for analyzing a glycomolecule Sep 30, 2010 Feb 21, 2012 Patent
Polysaccharide structure and sequence determination Nov 12, 2008 Jun 22, 2010 Patent